CLARAMETYX BIOSCIENCES
Clarametyx Biosciences is a late preclinical stage biotechnology company developing targeted, immune-enabling biologic therapies to counter persistent infections associated with biofilms.
CLARAMETYX BIOSCIENCES
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2020-01-01
Address:
Columbus, Ohio, United States
Country:
United States
Website Url:
http://www.clarametyx.com
Total Employee:
1+
Status:
Active
Contact:
614.686.2689
Email Addresses:
[email protected]
Total Funding:
21.24 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
CARB-X
CARB-X investment in Grant - Clarametyx Biosciences
National Institute of Deafness & Communications Disorders (NIDCD)
National Institute of Deafness & Communications Disorders (NIDCD) investment in Grant - Clarametyx Biosciences
CARB-X
CARB-X investment in Grant - Clarametyx Biosciences
Official Site Inspections
http://www.clarametyx.com Semrush global rank: 5.84 M Semrush visits lastest month: 1.42 K
- Host name: 77.71.72.148.host.secureserver.net
- IP address: 148.72.71.77
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Clarametyx Biosciences"
Clarametyx Biosciences - Crunchbase Company Profile …
May 27, 2021 Clarametyx Biosciences is a late preclinical stage biotechnology company. Clarametyx Biosciences may be growing as it has successfully raised a significant amount of capital through a Series A financing round, securing $33 …See details»
Clarametyx Bioscience, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Clarametyx Bioscience, Inc. of Columbus, OH. Get the latest business insights from Dun & Bradstreet.See details»
Clarametyx Biosciences - LinkedIn
Clarametyx Biosciences | 1,843 followers on LinkedIn. Thinking beyond antibiotics to fight life-threatening bacterial infections | Clarametyx Biosciences Inc. is a clinical stage biotechnology ...See details»
Get To Know Us - Clarametyx Biosciences
Guided by the discoverers and inventors of this novel approach as well as expert entrepreneurial leaders, we rigorously pursue our mission to deliver a powerful new tool to combat one of the …See details»
Clarametyx Biosciences - Contacts, Employees, Board Members, …
Organization. Clarametyx Biosciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of …See details»
Clarametyx Biosciences - PitchBook
Clarametyx Biosciences General Information Description. Developer of immune-facilitated biologic therapies designed to fight life-threatening infections. The company's novel technology …See details»
Clarametyx Bioscience Recognized as “Infectious Disease …
Nov 19, 2024 (“Clarametyx”), a biotechnology company developing targeted, immune-enabling biologic therapies to counter serious infections associated with biofilms, has been named …See details»
Clarametyx Biosciences - VentureRadar
The Clarametyx platform is designed to precisely remove a universal, pathogen-agnostic target within this matrix, rapidly and effectively collapsing the protective shield and sensitizing …See details»
Mission, Vision & Core Values of Clarametyx Biosciences
Clarametyx Biosciences is a cutting-edge biotechnology company dedicated to revolutionizing the field of biosciences through innovative research and development. Our mission is to improve …See details»
Clarametyx Initiates Phase 1 Study of Immune-enabling Antibody …
Nov 30, 2022 Clarametyx Initiates Phase 1 Study of Immune-enabling Antibody Therapy CMTX-101 Against Community-acquired Bacterial Pneumonia November 30, 2022 08:00 AM Eastern …See details»
Crumbling the Castle: Targeting DNABII Proteins for Collapsing ...
This article highlights the development of one such novel nontraditional product, CMTX-101, an anti-DNABII humanized monoclonal antibody being developed by Clarametyx Biosciences, …See details»
Clarametyx Biosciences Expands Board of Directors with …
COLUMBUS, Ohio – May 18, 2021 – Clarametyx Biosciences Inc. (“Clarametyx”), a preclinical stage biotechnology company developing targeted, immune-enabling biologic therapies to …See details»
Clarametyx Biosciences Expands Team Expertise to Accelerate …
COLUMBUS, Ohio, April 22, 2024--Clarametyx expands its team with experts in corporate and clinical development to accelerate progress with its anti-biofilm platform.See details»
CARB-X is funding Clarametyx Biosciences to develop an …
Nov 18, 2020 The World Health Organization (WHO) identifies these as priority bacterial threats. ... Clarametyx Biosciences is combating the formidable challenge of persistent and recalcitrant …See details»
Cystic Fibrosis Foundation part of $33M round for Columbus …
Jan 8, 2024 Clarametyx Biosciences Inc. has raised $33 million from backers including the Cystic Fibrosis Foundation to accelerate progress of its potential infection-busting treatment …See details»
Our Science - Clarametyx Biosciences
The Clarametyx Technology Therapeutic Approach | Vaccination Approach. Powerful Non-Antibiotic and pathogen-agnostic biologic technology. CMTX-101 (purple) antibodies capture …See details»
Clarametyx Biosciences Launches With an Ambitious ... - Business …
May 4, 2020 The Clarametyx platform has rapidly advanced through discovery, with the company’s lead candidate targeting the challenge of HAP. This high-burden disease presents …See details»
News & Updates - Clarametyx Biosciences
Nov 19, 2024 Clarametyx Biosciences Announces $33 Million Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections. Read More. June 1, 2023. Clarametyx …See details»
Clarametyx Biosciences Expands Team Expertise to Accelerate …
Apr 22, 2024 Clarametyx Biosciences is combating the formidable challenge of persistent and recalcitrant infections through an innovative technology platform targeting the biofilm—a …See details»